BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26250493)

  • 1. Unravelling the complexity of COPD by microRNAs: it's a small world after all.
    Osei ET; Florez-Sampedro L; Timens W; Postma DS; Heijink IH; Brandsma CA
    Eur Respir J; 2015 Sep; 46(3):807-18. PubMed ID: 26250493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of MicroRNAs in Chronic Obstructive Pulmonary Disease.
    Kara M; Kirkil G; Kalemci S
    Adv Clin Exp Med; 2016; 25(1):21-6. PubMed ID: 26935494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
    Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
    Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression networks in COPD: microRNA and mRNA regulation.
    Ezzie ME; Crawford M; Cho JH; Orellana R; Zhang S; Gelinas R; Batte K; Yu L; Nuovo G; Galas D; Diaz P; Wang K; Nana-Sinkam SP
    Thorax; 2012 Feb; 67(2):122-31. PubMed ID: 21940491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease.
    Akbas F; Coskunpinar E; Aynaci E; Oltulu YM; Yildiz P
    Exp Lung Res; 2012 Aug; 38(6):286-94. PubMed ID: 22686440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs in the pathogenesis of COPD.
    De Smet EG; Mestdagh P; Vandesompele J; Brusselle GG; Bracke KR
    Thorax; 2015 Aug; 70(8):782-91. PubMed ID: 25995155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of microRNAs in lung homogenates in rats with chronic obstructive pulmonary disease].
    Li B; Zhou X; Chen L; Feng C; Li T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Dec; 26(12):905-9. PubMed ID: 25476085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers.
    Xie L; Wu M; Lin H; Liu C; Yang H; Zhan J; Sun S
    Mol Biosyst; 2014 May; 10(5):1072-81. PubMed ID: 24556821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease.
    Barreiro E; Gea J
    Transl Res; 2015 Jan; 165(1):61-73. PubMed ID: 24794953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in lung diseases: Recent findings and their pathophysiological implications.
    Ebrahimi A; Sadroddiny E
    Pulm Pharmacol Ther; 2015 Oct; 34():55-63. PubMed ID: 26319446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of the sphingosine kinase signalling system in the lung of patients with chronic obstructive pulmonary disease.
    Cordts F; Pitson S; Tabeling C; Gibbins I; Moffat DF; Jersmann H; Hodge S; Haberberger RV
    Life Sci; 2011 Nov; 89(21-22):806-11. PubMed ID: 21945191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of chronic obstructive pulmonary disease.
    Fricker M; Deane A; Hansbro PM
    Expert Opin Drug Discov; 2014 Jun; 9(6):629-45. PubMed ID: 24754714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of microRNAs in the pathogenesis of chronic obstructive pulmonary disease.
    Huang X; Zhu Z; Guo X; Kong X
    Int Immunopharmacol; 2019 Feb; 67():335-347. PubMed ID: 30578969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
    Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
    Schamberger AC; Mise N; Meiners S; Eickelberg O
    Expert Opin Drug Discov; 2014 Jun; 9(6):609-28. PubMed ID: 24850530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic obstructive pulmonary disease and lung cancer: new molecular insights.
    Adcock IM; Caramori G; Barnes PJ
    Respiration; 2011; 81(4):265-84. PubMed ID: 21430413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease (COPD): An Update Review.
    Zhang L; Valizadeh H; Alipourfard I; Bidares R; Aghebati-Maleki L; Ahmadi M
    COPD; 2020 Jun; 17(3):333-342. PubMed ID: 32558592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of COPD.
    Spurzem JR; Rennard SI
    Semin Respir Crit Care Med; 2005 Apr; 26(2):142-53. PubMed ID: 16088433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD.
    Brandsma CA; van den Berge M; Postma DS; Jonker MR; Brouwer S; Paré PD; Sin DD; Bossé Y; Laviolette M; Karjalainen J; Fehrmann RS; Nickle DC; Hao K; Spanjer AI; Timens W; Franke L
    Thorax; 2015 Jan; 70(1):21-32. PubMed ID: 24990664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, chronic obstructive pulmonary disease and aging.
    Provinciali M; Cardelli M; Marchegiani F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S3-10. PubMed ID: 22209928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.